Author:
Austin M.-P. V.,Souza F. G. M.,Goodwin G. M.
Abstract
A quantitative analysis was used to examine the efficacy of lithium augmentation in the acute treatment of depressed patients resistant to a standard trial of an antidepressant. Effect sizes were measured by the odds ratio using the Mantel–Haenszel method. Only controlled trials were included in order to minimise bias in method. A highly statistically significant effect for lithium augmentation was found, the pooled odds ratio being 0.146 and its 95% confidence interval 0.05–0.44 (i.e. the odds of remaining ill are reduced by between 56% and 95% with the use of lithium treatment). While these results support the case for lithium augmentation in treatment-resistant depression, there remains considerable uncertainty over the duration of treatment necessary to see and sustain the treatment response.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference26 articles.
1. A Potential Clinical Use for Methylphenidate with Tricyclic Antidepressants
2. Treatment of Depressions Resistant to Tricyclic Antidepressants, Related Drugs or MAO-Inhibitors by Lithium Addition: Review of the Literature
3. The Benefit of Lithium Carbonate Adjunct in Refractory Depression — Fact or Fiction?
4. Lithium and treatment-resistant depressions: a review;Schou;Lithium,1990
5. Cournoyer G. , de Montigny C. , Ouellete J. , et al (1984) Lithium addition in tricyclic-resistant unipolar depression: a placebo-controlled study. Abstracts Collegium Internationale Neuro-Psychopharmacologicum Florence, June 19—23, 179.
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献